Renalase alleviates salt-induced kidney necroptosis and inflammation
- PMID: 39117946
- DOI: 10.1038/s41440-024-01814-4
Renalase alleviates salt-induced kidney necroptosis and inflammation
Abstract
Recent evidence suggests that necroptosis may contribute to the development of kidney injury. Renalase is a novel secretory protein that exerts potent prosurvival and anti-inflammatory effects. We hypothesized that renalase could protect the kidney from salt-induced injury by modulating necroptosis. High salt and renalase treatments were administered to Dahl salt-sensitive (SS) rats, renalase knockout (KO) mice, and HK-2 cells. Furthermore, a cohort of 514 eligible participants was utilized to investigate the association between single nucleotide polymorphisms (SNPs) in the genes RIPK1, RIPK3, and MLKL, and the risk of subclinical renal damage (SRD) over 14 years. A high-salt diet significantly increased the expression of key components of necroptosis, namely RIPK1, RIPK3, and MLKL, as well as the release of inflammatory factors in SS rats. Treatment with recombinant renalase reduced both necroptosis and inflammation. In renalase KO mice, salt-induced kidney injury was more severe than in wild-type mice, but supplementation with renalase attenuated the kidney injury. In vitro experiments with HK-2 cells revealed high salt increased necroptosis and inflammation. Renalase exhibited a dose-dependent decrease in salt-induced necroptosis, and this cytoprotective effect was negated by the knockdown of PMCA4b, which is the receptor of renalase. Furthermore, the cohort study showed that SNP rs3736724 in RIPK1 and rs11640974 in MLKL were significantly associated with the risk of SRD over 14 years. Our analysis shows that necroptosis plays a significant role in the development of salt-induced kidney injury and that renalase confers its cytoprotective effects by inhibiting necroptosis and inflammation.
Keywords: Inflammation; Kidney injury; Necroptosis; Renalase; Salt.
© 2024. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Similar articles
-
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.Cell Death Differ. 2016 Sep 1;23(9):1565-76. doi: 10.1038/cdd.2016.46. Epub 2016 May 13. Cell Death Differ. 2016. PMID: 27177019 Free PMC article.
-
7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.Phytomedicine. 2020 Apr;69:153202. doi: 10.1016/j.phymed.2020.153202. Epub 2020 Mar 2. Phytomedicine. 2020. PMID: 32169782
-
Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.Naunyn Schmiedebergs Arch Pharmacol. 2019 Sep;392(9):1085-1095. doi: 10.1007/s00210-019-01656-9. Epub 2019 May 5. Naunyn Schmiedebergs Arch Pharmacol. 2019. PMID: 31055628
-
Necroptosis-independent signaling by the RIP kinases in inflammation.Cell Mol Life Sci. 2016 Jun;73(11-12):2325-34. doi: 10.1007/s00018-016-2203-4. Epub 2016 Apr 5. Cell Mol Life Sci. 2016. PMID: 27048814 Free PMC article. Review.
-
The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.Int Rev Cell Mol Biol. 2017;328:253-275. doi: 10.1016/bs.ircmb.2016.08.007. Epub 2016 Sep 22. Int Rev Cell Mol Biol. 2017. PMID: 28069136 Free PMC article. Review.
References
-
- Malta D, Petersen KS, Johnson C, Trieu K, Rae S, Jefferson K, et al. High sodium intake increases blood pressure and risk of kidney disease. From the Science of Salt: A regularly updated systematic review of salt and health outcomes (August 2016 to March 2017). J Clin Hypertens (Greenwich). 2018;20:1654–65. - PubMed - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous